Qingxin Kaiqiao Fang decreases Tau hyperphosphorylation in Alzheimer's disease via the PI3K/Akt/GSK3β pathway in vitro and in vivo

被引:7
|
作者
Liu, Shuo [1 ,2 ,3 ]
Xu, Luting [1 ,2 ,3 ]
Shen, Yan [1 ,2 ,3 ]
Wang, Liuying [1 ,2 ,3 ]
Lai, Xiaoxiao [1 ,2 ,3 ]
Hu, Haiyan [1 ,2 ,3 ]
机构
[1] Wenzhou Med Univ, Affiliated Hosp 2, 109 Xue Yuan Xi Rd, Wenzhou 325000, Peoples R China
[2] Wenzhou Med Univ, Yuying Childrens Hosp, 109 Xue Yuan Xi Rd, Wenzhou 325000, Peoples R China
[3] Wenzhou Med Univ, Clin Coll 2, Wenzhou 325003, Peoples R China
基金
中国国家自然科学基金;
关键词
Alzheimer's disease; Qingxin Kaiqiao Fang; Traditional Chinese medicine; Tau APP/PS1; PI3K/Akt/GSK3 beta pathway; INDUCED APOPTOSIS; PC12; CELLS; BETA; INSULIN; INHIBITION; MECHANISMS; PATHOLOGY;
D O I
10.1016/j.jep.2023.117031
中图分类号
Q94 [植物学];
学科分类号
071001 ;
摘要
Ethnopharmacological relevance: Alzheimer's disease (AD) belongs to the category of "senile dementia" in traditional Chinese medicine. AD is associated with brain emptiness or collaterals blocked by phlegm-heat. "Fumanjian" from Jingyue Quanshu treats dementia by promoting qi circulation, alleviating depression, eliminating turbidity, cultivating positivity, and dispelling evil spirits. Qingxin Kaiqiao Fang (QKF), derived from Fumanjian, is effective in treating AD owing to previously mentioned clinical effects. Elucidating the mechanism (s) of action of QKF on AD associated with phlegm-heat may be beneficial for therapeutic management; however, further research is needed. Aim of the study: This study aimed to determine the role of the PI3K/Akt pathway in AD, especially the specific effector protein involved, and explore the efficacy of QKF in treating AD by modulating the PI3K/Akt signal. Materials and methods: High-performance liquid chromatography-Q-orbitrap-mass spectrometry was used to analyze the chemical components of QKF. Subsequently, APP/PS1 double-transgenic mice were used for behavioral tests, and hematoxylin-eosin and Nissl staining were used to assess the neuroprotective and cognitive effects of QKF. Cerebrospinal fluid pharmacology was used in in vitro validation, and A beta 25- 35 was used to induce PC12 cells to establish the AD cell model. Various methods, including immunohistochemistry, Western blotting, quantitative real-time polymerase chain reaction, morphological assay, cell counting kit-8(CCK-8) assay, and terminal deoxynucleotide transferase (TdT)-mediated dUTP nick-end labeling (TUNEL)staining, were used to evaluate the effect of QKF on Tau hyperphosphorylation and anti-apoptosis. These methods also assessed the influence of QKF on the PI3K/Akt/GSK3 beta pathway involving the mRNA and protein expressions. Finally, the inhibitor - LY294002 was used for reverse validation. Results: We identified 295 chemical components in the water extract of QKF.QKF improved spatial cognition and learning memory in APP/PS1 mice, protected PC12 cell morphology, improved cell survival, reduced A beta 25-35induced apoptosis, and inhibited the hyperphosphorylation of Tau protein via the PI3k/Akt/GSK3 beta signaling pathway. Furthermore, this protective effect of QKF was reduced by LY294002 in vitro. Conclusions: QKF can improve spatial cognition, learning, and memory abilities in APP/PS1 mice and protect PC12 cells. Decreasing the Tau hyperphosphorylation in AD exhibits curative efficacy on AD via the PI3K/Akt/ GSK3 beta pathway in vitro and in vivo.
引用
收藏
页数:15
相关论文
共 50 条
  • [41] Isoforsythiaside Attenuates Alzheimer's Disease via Regulating Mitochondrial Function Through the PI3K/AKT Pathway
    Wang, Chunyue
    Hao, Jie
    Liu, Xin
    Li, Chenliang
    Yuan, Xuyang
    Lee, Robert J.
    Bai, Tian
    Wang, Di
    [J]. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2020, 21 (16) : 1 - 18
  • [42] Neuroprotective effects of astaxanthin against oxygen and glucose deprivation damage via the PI3K/Akt/GSK3β/Nrf2 signalling pathway in vitro
    Zhang, Jie
    Ding, Changling
    Zhang, Shuping
    Xu, Yangyang
    [J]. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2020, 24 (16) : 8977 - 8985
  • [43] GSK3 and Tau: Two Convergence Points in Alzheimer's Disease
    Hernandez, Felix
    Lucas, Jose J.
    Avila, Jesus
    [J]. JOURNAL OF ALZHEIMERS DISEASE, 2013, 33 : S141 - S144
  • [44] Chrysotoxine attenuates sevoflurane-induced neurotoxicity in vitro via regulating PI3K/AKT/GSK pathway
    Qiu, Jin
    Zhang, Yi
    Xie, Mian
    [J]. SIGNA VITAE, 2021, 17 (04) : 185 - 191
  • [45] GSK3β inhibits epithelial-mesenchymal transition via the Wnt/β-catenin and PI3K/Akt pathways
    Zhang, Cheng
    Su, Li
    Huang, Li
    Song, Zheng-Yu
    [J]. INTERNATIONAL JOURNAL OF OPHTHALMOLOGY, 2018, 11 (07) : 1120 - 1128
  • [46] Intranasal Administration of GDNF Protects Against Neural Apoptosis in a Rat Model of Parkinson’s Disease Through PI3K/Akt/GSK3β Pathway
    Peijian Yue
    Lin Gao
    Xuejing Wang
    Xuebing Ding
    Junfang Teng
    [J]. Neurochemical Research, 2017, 42 : 1366 - 1374
  • [47] GSK3β inhibits epithelial-mesenchymal transition via the Wnt/β-catenin and PI3K/Akt pathways
    Cheng Zhang
    Li Su
    Li Huang
    Zheng-Yu Song
    [J]. International Journal of Ophthalmology, 2018, 11 (07) : 1120 - 1128
  • [48] Intranasal Administration of GDNF Protects Against Neural Apoptosis in a Rat Model of Parkinson's Disease Through PI3K/Akt/GSK3β Pathway
    Yue, Peijian
    Gao, Lin
    Wang, Xuejing
    Ding, Xuebing
    Teng, Junfang
    [J]. NEUROCHEMICAL RESEARCH, 2017, 42 (05) : 1366 - 1374
  • [49] Regulation of PI3K/Akt/GSK-3 pathway by cannabinoids in the brain
    Ozaita, Andres
    Puighermanal, Emma
    Maldonado, Rafael
    [J]. JOURNAL OF NEUROCHEMISTRY, 2007, 102 (04) : 1105 - 1114
  • [50] Electroacupuncture Protects Cognition by Regulating Tau Phosphorylation and Glucose Metabolism via the AKT/GSK3β Signaling Pathway in Alzheimer's Disease Model Mice
    Xu, Anping
    Zeng, Qingtao
    Tang, Yinshan
    Wang, Xin
    Yuan, Xiaochen
    Zhou, You
    Li, Zhigang
    [J]. FRONTIERS IN NEUROSCIENCE, 2020, 14